BD reports strong growth in 2015 business year

BD has announced strong financial results for its 2015 business year, which concluded on September 30th 2015.

Its adjusted revenues for the 12 months came to $10.3 billion (6.84 billion pounds), representing a year-on-year increase of 22 percent, or 29.5 percent on a currency-neutral basis.

The company's revenue total for the fourth quarter of the year was $3.07 billion, up by 49.1 percent on a currency-neutral basis, with the scale of this increase largely attributable to the takeover of CareFusion – the biggest acquisition in BD's history.

This has greatly expanded BD's capabilities and revenue in the medical sector, which more than offset the slight decline seen by its life science business.

It is now predicting a year-on-year revenue increase of 24.5 to 25 percent during the coming 2016 fiscal year.

Vincent Forlenza, chairman, chief executive officer and president of BD, said: "We enter fiscal 2016 with continued confidence in our ability to execute our strategy, deliver against our financial commitments and return value to our shareholders."